Change 5-day change 1-year change 3-year change Capi.($)
-.--%-95.00% - - 25
-1.52%+6.45%+34.93%+27.86% 24TCr
-0.87%+5.22%+7.85%-17.02% 15TCr
+2.61%+6.44%-9.84%+31.78% 14TCr
-0.17%+0.89%-55.86%-18.18% 6.31TCr
+0.12%+4.68%+18.47%+21.09% 5.09TCr
-1.69%-1.20%-20.18%-16.57% 4.91TCr
-0.29%+5.91%+21.94%+38.10% 4.41TCr
-1.64%+3.16%+37.50%+54.09% 4.22TCr
-2.82%+15.17%+130.77%+66.96% 3.7TCr
Average -0.66%+5.46%+18.40%+20.90% 9.05TCr
Weighted average by Cap. -0.54%+6.30%+14.92%+17.31%
Logo DiaSys Corporation
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Employees
10
  1. Stock Market
  2. Stocks
  3. DYXC Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!